Preparation method of bacterial polysaccharide and protein conjugate vaccine by using DSC as activating agent

A protein-binding vaccine, bacterial polysaccharide technology, applied in chemical instruments and methods, antibacterial drugs, bacterial antigen components, etc., can solve the problems of increased vaccine manufacturing cost, polysaccharide structure damage, long reaction period, etc., and achieve animal efficacy test results. Good, low free polysaccharide content, easy to operate

Inactive Publication Date: 2017-10-20
云南沃森生物技术股份有限公司
View PDF5 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

For example, CNBr is highly toxic, and when it is used for the activation of bacterial polysaccharides, it will cause certain pollution to the environment and there are some safety hazards in use; although CDAP is not as toxic as CNBr, the price of CDAP is relatively expensive, which increases the cost of vaccine manufacturing ;Sodium periodate is used as a polysaccharide activator, which destroys the polysaccharide structure, and oxidizes the hydroxyl group of the polysaccharide into an aldehyde group, and the whole reaction cycle is long, takes about 14 days, and the sodium periodate activation method has damage to the polysaccharide structure , there are many steps; EDAC, as a polysaccharide activator, has higher requirements on the polysaccharide structure, that is, the polysaccharide structure must contain free carboxyl groups, and EDAC activates the carboxyl groups in the polysaccharide and then connects with ADH to form polysaccharide-ADH derivatives

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Preparation method of bacterial polysaccharide and protein conjugate vaccine by using DSC as activating agent
  • Preparation method of bacterial polysaccharide and protein conjugate vaccine by using DSC as activating agent
  • Preparation method of bacterial polysaccharide and protein conjugate vaccine by using DSC as activating agent

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0028] Example 1 Preparation of Group A Meningococcal Polysaccharide-protein Conjugate and Its Animal Effectiveness Test

[0029] Preparation of Polysaccharide Derivatives from Group A Meningococcus

[0030] Weigh 200 mg of the purified polysaccharide of meningococcus group A and dissolve it with 0.2 mol / L NaCl solution to 5 mg / ml; weigh 500 mg of DSC and dissolve it with acetonitrile to 100 mg / ml; adjust the polysaccharide of group A meningococcus The pH value of the solution is 8.0-9.5, add DSC powder, maintain the pH value at 8.0-9.5 and react for 10 minutes, add 800 mg of adipic hydrazide, maintain the pH value at 8.5-9.0 and react for 40 minutes; use a 30KD ultrafiltration membrane to concentrate by ultrafiltration, The polysaccharide derivative of group A meningococcus (MenAps-ADH) was obtained by lyophilization.

[0031] Preparation of Group A Meningococcal Polysaccharide-Protein Conjugate

[0032] Take group A meningococcal polysaccharide derivative 150mg, be dissolv...

Embodiment 2

[0046] Example 2 Preparation of Haemophilus influenzae type b polysaccharide-protein conjugate and its animal effectiveness test

[0047] Preparation of polysaccharide derivatives from Haemophilus influenzae type b

[0048] Weigh 200 mg of purified Haemophilus influenzae type b polysaccharide, dissolve it with 0.2mol / L NaCl solution to 5 mg / ml; weigh 400 mg of DSC, dissolve it with acetonitrile to 100 mg / ml; adjust Haemophilus influenzae type b polysaccharide The pH value of the solution is 8.0-9.5, add DSC, maintain the pH value at 8.0-9.5 and react for 15 minutes, add 800 mg of adipic hydrazide, maintain the pH value at 8.5-9.0 and react for 20 minutes; concentrate with a 30KD ultrafiltration membrane, freeze Haemophilus influenzae type b polysaccharide polysaccharide derivative (Hibps-ADH) is obtained immediately after drying.

[0049] Preparation of Haemophilus influenzae type b polysaccharide-protein conjugate

[0050] Weigh 150 mg of Haemophilus influenzae type b polys...

Embodiment 3

[0064] Example 3 Preparation of pneumococcal 19F polysaccharide-protein conjugate and its animal effectiveness test

[0065] Preparation of Pneumococcal 19F Polysaccharide Derivatives

[0066] Weigh 200 mg of purified pneumococcal polysaccharide 19F, dissolve it with 0.2 mol / L NaCl solution to 5 mg / ml; weigh 300 mg of DSC, dissolve it with acetonitrile to 100 mg / ml; adjust the pH of the pneumococcal 19F polysaccharide solution to 8.0-9.5, add DSC, maintain the pH value of 8.0-9.5 and react for 20 minutes, add 800 mg of adipic hydrazide, maintain the pH value of 8.5-9.0 and react for 20 minutes; use a 30KD ultrafiltration membrane to concentrate by ultrafiltration and lyophilize to obtain pneumonia Coccoid 19F-type polysaccharide derivative (Pn19Fps-ADH).

[0067] Preparation of pneumococcal 19F polysaccharide-protein conjugate

[0068] Take by weighing pneumococcal 19F type polysaccharide derivative 150mg, be dissolved in the NaCl of 15ml 0.2mol / L, add tetanus toxoid solutio...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a preparation method of a bacterial polysaccharide and protein conjugate vaccine. The preparation method comprises the following step that before covalent binding of bacterial polysaccharide and protein, enabling bacterial polysaccharide and N,N'-disuccinimidyl carbonate (DSC) to generate activating reaction in an alkaline water solution with pH (potential of hydrogen) value of 8.0 to 9.5, so as to form the succinimidyl carbonate of the bacterial polysaccharide. The preparation method has the advantages that by using the N,N'-disuccinimidyl carbonate (DCS) as a bacterial polysaccharide activating agent, the toxicity is lower, the environment-friendly effect is realized, the cost is low, and the preparation cost of the vaccine is reduced; the activating time of polysaccharide is short, the number of steps is fewer, the whole binding cycle from polysaccharide activating to polysaccharide and protein binding is 4 to 5 days, the content of free polysaccharids is lower, and the animal immunogenicity is better.

Description

technical field [0001] The invention belongs to the technical field of vaccine preparation, and in particular relates to a preparation method of a bacterial polysaccharide-protein conjugated vaccine using DSC as an activator. Background technique [0002] At present, when preparing bacterial polysaccharide-protein conjugated vaccines at home and abroad, the bacterial polysaccharide activators used are cyanogen bromide (CNBr), 1-cyano-4-dimethylaminopyridine tetrafluoroborate (CDAP), sodium periodate , Carbodiimide (EDAC), these four kinds of polysaccharide activators have some deficiencies when activating bacterial polysaccharides. For example, CNBr is highly toxic. When it is used to activate bacterial polysaccharides, it will cause certain pollution to the environment and there are some safety hazards in use; although CDAP is not as toxic as CNBr, CDAP is relatively expensive, which increases the cost of vaccine manufacturing. ; Sodium periodate is used as a polysaccharid...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K39/095A61K39/102A61K39/09A61K47/18A61P31/04C07K14/33C07K14/34
CPCA61K39/09A61K39/095A61K39/102A61K47/18C07K14/33C07K14/34
Inventor 陈玉秋钱雯何建东范荣坤王丽丽陈敏王铭陆伟
Owner 云南沃森生物技术股份有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products